Insumedica
Insumédica is a Chilean B2B distributor of medical diagnostic products, representing international OEMs (Spinreact, CerTest, Alfa Scientific, Response Biomedical, ACON) and selling rapid tests, clinical chemistry reagents, coagulation tests, and point-of-care analyzers to healthcare facilities, laboratories, and occupational health customers across Chile.
- Company typePrivate
- Founded-
- HeadquartersRenca, Chile
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Insumedica does
Insumédica Comercial Limitada is a privately held Chilean limited partnership headquartered in Renca (Santiago Metropolitan Region) that distributes and commercializes medical diagnostic products for the Chilean market. The company represents international manufacturers of rapid tests, clinical chemistry reagents, coagulation reagents, latex agglutination tests, and point-of-care analyzers, and sells to healthcare facilities, clinical laboratories, hospital departments, and occupational health organizations across Chile. Its catalog spans more than forty listed SKUs across infectious disease screening (influenza, SARS-CoV-2 + RSV combos, Helicobacter pylori, hepatitis, sexually transmitted infections), drug and alcohol detection panels, cardiac and tumor markers, pregnancy and urinalysis, blood glucose, plus clinical chemistry reagents for glucose, urea, triglycerides, calcium, total proteins, and fibrinogen, among others.
The underlying technology is not proprietary to Insumédica; rather, the company carries third-party platforms and assays including the Response Biomedical RAMP 200 multiparametric point-of-care analyzer, Alfa Scientific Designs lateral flow drug panels, CerTest Biotec immunochromatographic tests, ACON Biotech's ON CALL PLUS electrochemical glucometer, and Spinreact clinical chemistry and latex reagents. Many of these carry FDA, CE, and ISO 9001 certifications inherited from the OEMs. The company ships nationally via Chilexpress and operates a quote-based e-commerce storefront at insumedica.cl supplemented by direct email and WhatsApp sales for bulk and institutional orders.
The business model is straightforward B2B distribution: revenue is generated on one-time product sales (medical devices and reagents) at quote-based pricing, with a direct sales motion for larger institutional accounts. Go-to-market is hybrid — digital (e-commerce site, LinkedIn, Instagram) at the top of the funnel, and direct sales via email and WhatsApp at the bottom of the funnel. The recent November 2025 addition of the RAMP 200 instrument platform signals a deliberate expansion from pure consumables into instrument-plus-reagent critical-care diagnostics, while horizontal product breadth across multiple OEMs allows Insumédica to serve as a consolidated diagnostic consumables supplier for Chilean laboratory buyers.
Insumedica firmographics
Firmographics- Name
- Insumedica
- Legal name
- Insumédica Comercial Limitada
- Website
- https://insumedica.cl
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Insumédica is a Chilean B2B distributor of medical diagnostic products, representing international OEMs (Spinreact, CerTest, Alfa Scientific, Response Biomedical, ACON) and selling rapid tests, clinical chemistry reagents, coagulation tests, and point-of-care analyzers to healthcare facilities, laboratories, and occupational health customers across Chile.
- Ownership category
- akta.pro rank
Where Insumedica is headquartered
LocationHeadquarters
- HQ city
- Renca
- HQ country
- Chile
- HQ region
- Latin America
Offices1 record
Markets served
Insumedica business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Medical Diagnostic Products Distribution: Insumédica generates revenue through the distribution and commercialization of medical diagnostic reagents, rapid tests, and laboratory equipment from international manufacturers to healthcare facilities and laboratories in Chile. The company acts as a representative and distributor for multiple prestigious international diagnostic brands, selling products across categories including rapid tests, clinical chemistry, coagulation, and latex-based diagnostics. Revenue is generated through direct product sales with quote-based pricing for different customer segments.
- Bulk/Volume Order Sales: For large volume or bulk purchases, Insumédica handles orders through direct email communication ([email protected]), indicating a B2B sales model for institutional customers requiring larger quantities of diagnostic products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard retail pricing for individual products |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Insumedica product offering
Product offeringCore offering
Insumédica Comercial Limitada is a Chilean distributor and commercializer of human diagnostic products, representing international manufacturers (Spinreact, CerTest, Alfa Scientific, Response Biomedical, ACON Biotech, Hangzhou Tongzhou Biotechnology) and selling rapid tests, clinical chemistry reagents, coagulation tests, latex agglutination tests, and point-of-care diagnostic analyzers to healthcare facilities and laboratories throughout Chile.
Product overview
Insumédica is a Chilean distributor of human diagnostics, representing and commercializing reagents and tests from prestigious international brands. The portfolio consists of a unified catalog of physical diagnostic products organized into four main categories: Test Rápidos (Rapid Tests) covering drug detection, infectious diseases, cardiac markers, tumor/inflammatory markers, pregnancy, urinalysis, and blood glucose; Química Clínica (Clinical Chemistry) including liquid reagents, turbidimetry, and liquid enzymes; Coagulation tests; and Latex agglutination tests. Notable branded products include the RAMP 200 Point of Care analyzer (Response Biomedical) for critical care diagnostics, the ON CALL PLUS glucometer system (ACON Biotech), and extensive rapid test product lines from Alfa Scientific Designs (Instant View), CerTest Biotec (Certest), and Hangzhou Tongzhou Biotechnology (Hindering), alongside clinical chemistry reagents from Spinreact (Girona, Spain).
Differentiator
Problem solved
Functional benefit
Products and services
- RAMP 200 Analyzer Multiparametric Point of Care (POC) analyzer that delivers quantitative diagnostic results with laboratory-quality accuracy in approximately 15 minutes for cardiovascular events and sepsis management. Processes up to 6 samples simultaneously and accepts whole blood without centrifugation.
- ON CALL PLUS Glucometer Portable digital glucometer system for monitoring capillary and venous blood glucose levels in diabetes management, with electrochemical biosensor technology and 300-result internal memory.
- MULTI 12 (panel multidrogas) Qualitative rapid test for simultaneous detection of 12 drug classes (AMP, BAR, BZO, COC, MET, OPI, MTD, PCP, PPX, TCA, THC, XTC) using lateral flow immunochromatic assay with monoclonal antibodies, read visually in 4-7 minutes. FDA and CE certified.
- MULTI 5 (panel multidrogas) Qualitative rapid test for simultaneous detection of 5 drugs (Amphetamines, Benzodiazepines, Cocaine, Opiates, Marijuana) using competitive lateral flow immunochromatic assay with colloidal gold-labeled monoclonal antibodies.
- Influenza A + B (CerTest) Qualitative rapid test for detection and differentiation of Influenza A and Influenza B antigens using lateral flow immunochromatic assay, with sensitivity exceeding 99% for both types compared to cell culture. CE and ISO certified.
- Influenza A+B (Hindering) Qualitative rapid test for detection of Influenza A and B antigens using lateral flow immunochromatic assay with 95.1-100% sensitivity for Type A and 94.2-97.9% for Type B. CE and ISO certified.
- SARS-CoV-2 + Flu A + Flu B Combo Test Quadruple antigen detection combo card for simultaneous identification of SARS-CoV-2, Influenza A, Influenza B, and RSV antigens from nasopharyngeal swabs using lateral flow immunochromatic assay.
- Helicobacter pylori fecales Qualitative rapid test for detection of Helicobacter pylori antigens in stool samples for diagnosis of active infection, with sensitivity exceeding 94%.
- Helicobacter pylori (serum/whole blood) Qualitative rapid test for detection of Helicobacter pylori IgG antibodies in serum or whole blood with 95.1% sensitivity.
- Troponina I Rapid Test Qualitative rapid test for Troponin I detection for myocardial infarction diagnosis with 1.5 ng/mL sensitivity. Results read between 5-15 minutes.
- PSA (Prostate Specific Antigen) Rapid Test Qualitative or semi-quantitative rapid test for Prostate Specific Antigen (PSA) detection with 4 ng/mL sensitivity for prostate cancer screening.
- Hepatitis B (HBsAg) Rapid Test Qualitative rapid test for Hepatitis B Surface Antigen (HBsAg) detection in serum or plasma with 2 ng/mL sensitivity.
- Fibrinógeno (Clauss Method) Quantitative determination of Fibrinogen using functional coagulation assay based on Clauss Method with bovine thrombin, requiring citrated human plasma.
- Calcio III (Arsenazo III) Quantitative calcium quantification using colorimetric Arsenazo III reaction forming a blue complex for diagnosing bone, renal, or endocrine disorders.
- Glucosa (GOD-POD) Quantitative glucose determination using enzymatic colorimetric GOD-POD method with 10-minute incubation at 37°C or 20 minutes at room temperature.
- Urea (UV kinetic)
Quantifiable outcome
- Over 60 diagnostic products available in Chile from internationally certified manufacturers
Companies that use Insumedica
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Insumedica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Insumedica partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Response BiomedicalcoreResponse Biomedical developed the RAMP 200 point-of-care analyzer. Insumédica announced the incorporation of the RAMP 200 to their catalog in November 2025, expanding their point-of-care diagnostic offerings in Chile.
- Spinreact S.A.U.coreSpinreact (Girona, España) is a leading Spanish manufacturer of clinical chemistry reagents and diagnostic products. Insumédica represents and distributes Spinreact products in Chile, offering over 60 products including clinical chemistry reagents, enzymes, turbidimetry tests, and latex diagnostics.
- CerTest Biotec S.L.coreCerTest Biotec (Zaragoza, España) specializes in immunochromatographic rapid tests. Insumédica distributes CerTest products including Influenza A+B tests, SARS-CoV-2 combo tests, and gastrointestinal disease tests in Chile.
- Alfa Scientific Designs Inc.coreAlfa Scientific Designs (Poway, California, USA) manufactures rapid drug testing products. Insumédica distributes Alfa products in Chile including multi-panel drug tests with FDA and CE certifications.
- ACON Biotech (Hangzhou) Co., Ltd.minorACON Biotech (Zhejiang, China) manufactures glucometers and related diagnostic products including the ON CALL PLUS glucose monitoring system. Insumédica distributes ACON products in Chile.
- Hangzhou Tongzhou Biotechnology Co., Ltd. (Hindering brand)minorHangzhou Tongzhou Biotechnology manufactures rapid diagnostic tests under the Hindering brand. Products distributed include Influenza A+B tests, infectious disease tests, and drug screening products.
Scale indicators1 record
Recent moves6 records
Expansion highlights4 records
Insumedica competitors and assessment
Company assessmentBroad incumbents
- BioMérieux: Global in vitro diagnostics company with a direct Chile subsidiary selling microbiology, clinical chemistry reagents, and immunoassays to hospitals and labs. Comparable because it distributes overlapping diagnostic product categories (clinical chemistry, infectious disease) into the same Chilean hospital/laboratory end-market that Insumédica serves via its distribution model.
- Roche Diagnostics: World-leading IVD manufacturer with direct Chile presence across clinical chemistry, immunoassays, and molecular diagnostics. Comparable as a competing supplier of the diagnostic reagent and analyzer categories Insumédica distributes, often displacing third-party distributors with direct sales to large Chilean accounts.
- Sysmex: Global leader in hematology and IVD with Chile presence selling coagulation, hematology analyzers, and reagents. Comparable because its coagulation/hematology lines overlap directly with Insumédica's Spinreact coagulation reagents and compete for Chilean lab procurement share.
- Siemens Healthineers: Major IVD and imaging vendor with a Chilean subsidiary selling clinical chemistry, immunoassay, and coagulation systems. Comparable because its coagulation and clinical chemistry reagent lines directly overlap with Spinreact products distributed by Insumédica and compete for the same hospital lab procurement budgets.
- Mindray: Chinese-origin global medical device and IVD manufacturer with growing Latin America distribution including clinical chemistry analyzers and reagents. Comparable as an alternative supplier to Chilean labs in the clinical chemistry and POC categories where Insumédica distributes competing brands.
- QuidelOrtho: IVD company focused on immunoassays, rapid diagnostics, and blood banking — including lateral flow rapid tests for infectious disease and drugs of abuse. Comparable because its rapid test categories (respiratory, infectious disease, drug screening) directly overlap with the Alfa Scientific, CerTest, and Hindering lines Insumédica distributes in Chile.
- Werfen: Specialty diagnostics company with presence across Latin America in hemostasis, autoimmunity, and infectious disease. Comparable because its coagulation and specialty diagnostics portfolio overlaps with Insumédica's Spinreact coagulation/latex and CerTest infectious disease lines into Chilean hospital labs.
- Hologic: Global diagnostics and women's health company with molecular and rapid diagnostic offerings sold across Latin America. Comparable as a supplier of molecular and rapid infectious-disease diagnostics that compete for Chilean hospital lab procurement against Insumédica's distributed rapid test portfolio.
- Abbott Diagnostics: Global diagnostics company with Chile operations covering immunoassays, clinical chemistry, point-of-care, and rapid tests. Comparable as a competing supplier to Chilean labs and hospitals across overlapping test categories (infectious disease, cardiac markers, drug screening) that Insumédica's catalog also serves.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Insumedica social profiles
Digital presenceInsumedica compliance and trust
Trust signalCompliance16 records
Insumedica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Insumedica leadership team
Management profileNumber of profiles
Insumedica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Insumedica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Insumedica
What does Insumedica do?
Insumédica Comercial Limitada is a Chilean distributor and commercializer of human diagnostic products, representing international manufacturers (Spinreact, CerTest, Alfa Scientific, Response Biomedical, ACON Biotech, Hangzhou Tongzhou Biotechnology) and selling rapid tests, clinical chemistry reagents, coagulation tests, latex agglutination tests, and point-of-care diagnostic analyzers to healthcare facilities and laboratories throughout Chile.
Is Insumedica a public or private company?
Insumedica is a private company. It is classified as unknown and is currently operating.
When was Insumedica founded?
Insumedica was founded in -1. It employs 1 to 10 people.
Where is Insumedica based?
Insumedica is headquartered in Renca, Chile, in the Latin America region.
How does Insumedica make money?
Two revenue lines are on record. Medical Diagnostic Products Distribution is the primary driver. The others are bulk/Volume Order Sales.
Who are Insumedica's main competitors?
Broad incumbents on record are BioMérieux, Roche Diagnostics, Sysmex, Siemens Healthineers, Mindray, QuidelOrtho, Werfen, Hologic and Abbott Diagnostics.
Does Insumedica have an API?
No public API is recorded for Insumedica.